Unspecified TYK2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified TYK2 inhibitor, covering 2025-11-18 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis [NA]